National Institute for Health & Care Excellence

node taxonomy

Narcolepsy UK Charter adds our collective voice to enable new nationally recommended treatment for excessive daytime sleepiness in adults with narcolepsy with or without cataplexy in England and Wales.

Blog post

18 November 2021

charter, National Institute for Health & Care Excellence, NICE, Solriamfetol, Sunosi, medication, sleep medicine

Narcolepsy UK Charter adds our collective voice to enable new nationally recommended treatment for excessive daytime sleepiness in adults with narcolepsy with or without cataplexy in England and Wales.

National Institute for Health and Care Excellence (NICE) has recommended solriamfetol as an option for treating excessive daytime sleepiness in adults with narcolepsy if modafinil and either dexamfetamine or methylphenidate have not worked well enough or are not suitable.